Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergey Mishinov

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Surgical Neurology International|March 26, 2021
A titanium implant for Chiari malformation Type 1 surgerySergey Mishinov, Alexander Samokhin, Andrey Panchenko, et al.
Life (Basel, Switzerland)|October 23, 2021
Double Recombinant Vaccinia Virus: A Candidate Drug against Human GlioblastomaNatalia Vasileva, Alisa Ageenko, Maria Dmitrieva, et al.
International Journal of Molecular Sciences|April 27, 2024
The Recombinant Oncolytic Virus VV-GMCSF-Lact and Chemotherapy Drugs against Human GliomaNatalia Vasileva, Alisa Ageenko, Arina Byvakina, et al.
International Journal of Molecular Sciences|April 25, 2020
Defective Regulation of Membrane TNFα Expression in Dendritic Cells of Glioblastoma Patients Leads to the Impairment of Cytotoxic Activity against Autologous Tumor CellsTamara Tyrinova, Olga Leplina, Sergey Mishinov, et al.
International Journal of Molecular Sciences|August 28, 2025
Exploring the Heterogeneity of Cancer-Associated Fibroblasts via Development of Patient-Derived Cell Culture of Breast CancerAnna Ilyina, Anastasia Leonteva, Ekaterina Berezutskaya, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 23, 2018
Defective Dendritic Cell Cytotoxic Activity of High-Grade Glioma Patients' Results from the Low Expression of Membrane TNFα and Can Be Corrected In Vitro by Treatment with Recombinant IL-2 or Exogenic Double-Stranded DNATamara Tyrinova, Olga Leplina, Sergey Mishinov, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Surgical Neurology International|March 26, 2021
A titanium implant for Chiari malformation Type 1 surgerySergey Mishinov, Alexander Samokhin, Andrey Panchenko, et al.
Life (Basel, Switzerland)|October 23, 2021
Double Recombinant Vaccinia Virus: A Candidate Drug against Human GlioblastomaNatalia Vasileva, Alisa Ageenko, Maria Dmitrieva, et al.
International Journal of Molecular Sciences|April 27, 2024
The Recombinant Oncolytic Virus VV-GMCSF-Lact and Chemotherapy Drugs against Human GliomaNatalia Vasileva, Alisa Ageenko, Arina Byvakina, et al.
International Journal of Molecular Sciences|April 25, 2020
Defective Regulation of Membrane TNFα Expression in Dendritic Cells of Glioblastoma Patients Leads to the Impairment of Cytotoxic Activity against Autologous Tumor CellsTamara Tyrinova, Olga Leplina, Sergey Mishinov, et al.
International Journal of Molecular Sciences|August 28, 2025
Exploring the Heterogeneity of Cancer-Associated Fibroblasts via Development of Patient-Derived Cell Culture of Breast CancerAnna Ilyina, Anastasia Leonteva, Ekaterina Berezutskaya, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 23, 2018
Defective Dendritic Cell Cytotoxic Activity of High-Grade Glioma Patients' Results from the Low Expression of Membrane TNFα and Can Be Corrected In Vitro by Treatment with Recombinant IL-2 or Exogenic Double-Stranded DNATamara Tyrinova, Olga Leplina, Sergey Mishinov, et al.
Pageof 1